$PTCT PTC THERAPEUTICS, INC. Insider Trading Week 27/2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in PTC THERAPEUTICS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in PTC THERAPEUTICS, INC. in week 27/2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 09 2019 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Option Exercise | M | 18.01 | 4,375 | 78,794 | 43,750 | |
| Jul 09 2019 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Option Exercise | M | 18.01 | 4,375 | 78,794 | 48,125 | |
| Jul 09 2019 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Option Exercise | M | 11.23 | 3,281 | 36,846 | 19,688 | |
| Jul 09 2019 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Option Exercise | M | 11.23 | 3,281 | 36,846 | 22,969 | |
| Jul 09 2019 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Sell | S | 45.34 | 1,441 | 65,329 | 29,524 | 31 K to 29.5 K (-4.65 %) |
| Jul 09 2019 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Sell | S | 44.45 | 2,934 | 130,428 | 30,965 | 33.9 K to 31 K (-8.66 %) |
| Jul 09 2019 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Buy | M | 18.01 | 4,375 | 78,794 | 33,899 | 29.5 K to 33.9 K (+14.82 %) |
| Jul 09 2019 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Sell | S | 45.31 | 1,399 | 63,394 | 29,524 | 30.9 K to 29.5 K (-4.52 %) |
| Jul 09 2019 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Sell | S | 44.46 | 2,976 | 132,313 | 30,923 | 33.9 K to 30.9 K (-8.78 %) |
| Jul 09 2019 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Buy | M | 18.01 | 4,375 | 78,794 | 33,899 | 29.5 K to 33.9 K (+14.82 %) |
| Jul 09 2019 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Sell | S | 45.34 | 1,098 | 49,787 | 29,524 | 30.6 K to 29.5 K (-3.59 %) |
| Jul 09 2019 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Sell | S | 44.46 | 2,183 | 97,047 | 30,622 | 32.8 K to 30.6 K (-6.65 %) |
| Jul 09 2019 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Buy | M | 11.23 | 3,281 | 36,846 | 32,805 | 29.5 K to 32.8 K (+11.11 %) |
| Jul 09 2019 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Sell | S | 45.34 | 1,000 | 45,342 | 29,524 | 30.5 K to 29.5 K (-3.28 %) |
| Jul 09 2019 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Sell | S | 44.48 | 2,281 | 101,457 | 30,524 | 32.8 K to 30.5 K (-6.95 %) |
| Jul 09 2019 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Buy | M | 11.23 | 3,281 | 36,846 | 32,805 | 29.5 K to 32.8 K (+11.11 %) |